Two surgical mesh brands used off-label in breast reconstruction surgery have had “significantly higher major complication rates,” according to an FDA analysis. Patients implanted with  FlexHD by MTF Biologics and AlloMax by BD had

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In